BioCentury
ARTICLE | Clinical News

BSD-2000: Phase III started

February 15, 2010 8:00 AM UTC

BSD began an international Phase III trial to evaluate gemcitabine with or without the BSD-2000 Hyperthermia System in pancreatic cancer patients with surgical tumor resection. ...